Results

CBP - U.S. Customs and Border Protection

07/20/2020 | Press release | Distributed by Public on 07/20/2020 08:13

Banned Prescription Medication Seized by CBP in Indianapolis

INDIANAPOLIS- U.S. Customs and Border Protection (CBP) officers at an Indianapolis express consignment facility recently seized multiple shipments of Zolpidem, 10 milligram tablets, a schedule IV substance under the Controlled Substance Act.

The shipments were arriving from the United Kingdom and were all headed to separate addresses. The pills were concealed in six different parcels and were hidden in coffee tins. CBP officers inspected the shipment based on shared critical information.

'Most people hear about CBP seizing narcotics shipments,' said James Moore, Port Director, Indianapolis. 'However shipments of illegal prescription pills are very dangerous too. These pills were not regulated by the FDA and can contain harmful chemicals that could be poisonous.'

Zolpidem, is a sedative, also called a hypnotic. It affects chemicals in the brain that may be unbalanced in people with sleep problems (insomnia). Continued use of Zolpidem may lead to dependency. For the stated reason of its potential for recreational use and dependence, Zolpidem is a Schedule IV substance under the Controlled Substances Act.

CBP provides basic import information about admissibility requirements and the clearance process for e-commerce goods and encourages buyers to confirm that their purchases and the importation of those purchases comply with any state and federal import regulations.

CBP conducts operations at ports of entry throughout the United States, and regularly screens arriving international passengers and cargo for narcotics, weapons, and other restricted or prohibited products. CBP strives to serve as the premier law enforcement agency enhancing the Nation's safety, security, and prosperity through collaboration, innovation, and integration.